True Vision Diagnostics Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-07-2024
- Paid Up Capital ₹ 0.40 M
as on 03-07-2024
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.50 M
as on 03-07-2024
- Satisfied Charges ₹ 2.50 M
as on 03-07-2024
- Revenue -16.27%
(FY 2021)
- Profit 113.01%
(FY 2021)
- Ebitda -95.03%
(FY 2021)
- Net Worth 4.35%
(FY 2021)
- Total Assets 56.16%
(FY 2021)
About True Vision Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹1.05 Cr. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Saakshi Kerkar and Amol Kerkar serve as directors at the Company.
- CIN/LLPIN
U33110MH2003PTC138693
- Company No.
138693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2003
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does True Vision Diagnostics Private Limited offer?
True Vision Diagnostics Private Limited offers a wide range of products and services, including IVDs & Analyzers, Hematology Analyzers, Medical Laboratory Instruments, Cell Counter, Blood Gas Analyzer.
Who are the key members and board of directors at True Vision Diagnostics?
Board Members(2)
Financial Performance and Corporate Structure Insights of True Vision Diagnostics.
True Vision Diagnostics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 16.27% decrease. The company also saw a substantial improvement in profitability, with a 113.01% increase in profit. The company's net worth moved up by a moderate rise of 4.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of True Vision Diagnostics?
In 2019, True Vision Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Mar 2021 | ₹1.05 Cr | Open |
Canara Bank Creation Date: 15 Mar 2007 | ₹2.00 M | Satisfied |
Canara Bank Creation Date: 31 May 2004 | ₹0.50 M | Satisfied |
How Many Employees Work at True Vision Diagnostics?
Unlock and access historical data on people associated with True Vision Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of True Vision Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped True Vision Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
